Origin SPAC Presentation Deck slide image

Origin SPAC Presentation Deck

Illustrative valuation references - valuation benchmarking Specialty Chemicals 2021E EV/ Revenue 2021E EV / EBITDA 1.2x i 2026E i i 2027E i 3.4x i 2026E 0.7x ORIGIN 1.7x 1- i 2027E 7.6x 21.6x novozymes Mean: 5.7x 6.4x Mean: 20.6x 24.3x 5.3x ALBEMARLE 18.5x CRODA 3.5x 18.0x DSM 31.1x 46.7x danimer (¹) Source: Origin Materials Consolidated Financials; company projections based on company filings and FactSet as of January 29, 2021. Note: Companies are ordered in descending 2021E EV / Revenue. 1. Danimer metrics based on 2023E EBITDA. 2. Plug Power and Desktop Metal multiples based on 2024E / 2025E. Biochemicals/Biomaterials 17.3x NM Mean: 13.4x 7.8x Mean: 30.3x NM O 7.7x avar 25.9x 3.1x 18.2x 24.0x Corbion 115.5x Disruptive technology POWG 20.2x 106.1x Mean: 17.0x صورت به سی امن میں لیا 19.2x Mean: 109.7x 256.4x 12.4x 29.6x sunrun 9.4x 41.1x ORIGIN 45 D Desktop Metal (2)
View entire presentation